ShareValue.ai

ShareValue scores for KNB.LSE: Valuation 68, Quality 27, Growth 77, Health 56.

KNB.LSE
LSE

Kanabo Group PLC

£0.23(+2.27%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

8% to 20%
Valuation
68
Fair Value
Price vs Value
Quality
27
Weak
Business Strength
Growth
77
Strong
Revenue & Earnings
Health
56
Moderate
Financial Stability
Momentum
49
Neutral
Price Trend

Company Details

About

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026